At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent ...
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of ...
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical ...
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, ...
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...
FDA's plan to use AI to speed up trials, Hinge's new migraine device, and boosting cancer screening with texts.
A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family ...
Michael Burgess and Larry Bucshon, former Republican congressmen and doctors, weigh in on RFK Jr.’s recent congressional ...
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results